Drug
Incb000928
Incb000928: highest development phase Phase 2, developed by Incyte. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Incyte
Trials
| Drug | Phase | Indication |
|---|---|---|
| INCB000928 NCT05090891 | Phase 2 | Fibrodysplasia Ossificans Progressiva (FOP) |
| INCB000928 NCT04455841 | Phase 1/2 | Anemia |
Latest
Follow Incb000928 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.